Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 1.07B 936M 865M 796M 1.5B 103B 1.53B 10.35B 4.06B 50.39B 4.01B 3.92B 174B P/E 2026 *
-23.4x
P/E 2027 * -31.1x
Enterprise Value 1.08B 948M 876M 806M 1.52B 104B 1.54B 10.48B 4.11B 51.02B 4.06B 3.97B 176B EV / Sales 2026 *
5.14x
EV / Sales 2027 * 4.58x
Free-Float
41.44%
Yield 2026 *
-
Yield 2027 * -
1 day-1.45%
1 week+12.34%
Current month+14.50%
1 month+36.10%
3 months+97.92%
6 months+90.53%
Current year+119.85%
1 week 6.33
Extreme 6.33
7.3
1 month 5.09
Extreme 5.09
7.3
Current year 2.8
Extreme 2.8
7.3
1 year 1.99
Extreme 1.99
7.3
3 years 1.66
Extreme 1.665
12.92
5 years 1.66
Extreme 1.665
63.55
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
6/30/26 Tax

Chief Financial Officer

-65,584 0.0445%
6/10/26 Sell

General Counsel

-25,000 0.0169%
Change 5-day change 1-year change 3-year change Capi.($)
-2.28%+12.34%+200.21%-42.93% 1.07B
+0.95%-.--%+107.91%+6.38% 20.03B
-2.59%+1.53%+153.41%+108.28% 4.72B
-4.23%+5.23%+114.55%+187.27% 3.67B
+0.90%+24.56%+102.10%-33.96% 2.23B
-2.64%+33.78%+201.76%+283.60% 2.05B
+1.47%+0.72%-28.63%-36.65% 2.04B
-6.83%-8.28%-16.88%+25.18% 875M
-1.43%+4.66%-35.15%-12.68% 513M
-13.37%-16.12%-16.80% - 476M
Average -2.86%+6.99%+78.25%+53.83% 3.77B
Weighted average by Cap. -0.49%+4.83%+107.84%+46.44%

Financials

2026 *2027 *
Net sales 210M 184M 170M 157M 296M 20.29B 301M 2.04B 799M 9.93B 790M 773M 34.21B 226M 198M 183M 168M 318M 21.78B 323M 2.19B 858M 10.66B 848M 830M 36.71B
Net income -39.2M -34.36M -31.76M -29.21M -55.11M -3.78B -55.99M -380M -149M -1.85B -147M -144M -6.37B -28.2M -24.72M -22.85M -21.01M -39.65M -2.72B -40.28M -273M -107M -1.33B -106M -104M -4.58B
Net Debt 13.46M 11.79M 10.9M 10.03M 18.92M 1.3B 19.22M 130M 51.1M 635M 50.53M 49.43M 2.19B -33.46M -29.33M -27.11M -24.94M -47.05M -3.23B -47.8M -324M -127M -1.58B -126M -123M -5.44B
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
416
Date Price Change Volume
26-07-20 US$7.100 -1.93% 1,149,250
26-07-17 US$7.240 +2.12% 2,845,187
26-07-16 US$7.090 +0.71% 5,237,987
26-07-15 US$7.040 +8.14% 4,808,483
26-07-14 US$6.510 +2.36% 6,440,545
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.240USD
Average target price
5.900USD
Spread / Average Target
-18.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock